Trial intelligence / Profile preview

Methotrexate Alone vs Methotrexate Combined With Etanercept in JIA

NCT07386587Phase 3Enrolling by invitation

Sponsor
University of Child Health Sciences and Children's Hospital, Lahore
Start
Jan 2026
Primary completion
Jul 2026
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 3 trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Started Jan 2026; status: enrolling by invitation.

02

Drugs

etanercept
03

Conditions

juvenile idiopathic arthritis (JIA)

Beyond the preview

Go deeper on NCT07386587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07386587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call